Pfizer Inc

{ "date": [ "202612", "202712", "202812" ], "revenue_estimate": [ 61228.84, 59041.54, 54918.11 ], "ebit_estimate": [ 21175.07, 20049.24, 17392.11 ], "ebitda_estimate": [ 24366.53, 23426.49, 20280.77 ], "net_income_estimate": [ 16872.39, 16101.24, 14083.97 ], "per_share_eps_estimate": [ 2.18, 2.04, 1.88 ], "eps_nri_estimate": [ 2.96, 2.82, 2.47 ], "dividend_estimate": [ 1.75, 1.77, 1.75 ], "book_value_per_share_estimate": [ 16.35, 16.37, 16.41 ], "pretax_income_estimate": [ 19703.12, 18781.23, 16246.26 ], "operating_cash_flow_per_share_estimate": [ 3.41, 3.29, 2.97 ], "roa_estimate": [ 7, 5.95, 4.9 ], "roe_estimate": [ 17.57, 16.18, 14.36 ], "gross_margin_estimate": [ 75.38, 75.4, 75.01 ], "operating_cash_flow_estimate": [ 19482.27, 18813.94, 16984.61 ], "pettm_estimate": [ 12.77, 13.64, 14.8 ], "long_term_growth_rate_mean": -8.1, "long_term_revenue_growth_rate_mean": "-4.19", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": -8.1, "future_revenue_estimate_growth": -4.19, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": 25.39, "future_book_value_per_share_estimate_growth": 2.31, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202603", "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 13890.17, 14480.74, 16137.14, 16572.71, 13430.92, 14051.79, 15553.8, 15963.64 ], "ebit_estimate": [ 5312.73, 5155.64, 6149.85, 4669.63, 5060, 5080, 5996, 4230 ], "ebitda_estimate": [ 6556.52, 6389.57, 7038.76, 5111.27, null, null, null, null ], "net_income_estimate": [ 4195.79, 4090.15, 4927.2, 3684.87, 4093, 4073, 4863, 3378 ], "per_share_eps_estimate": [ 0.55, 0.55, 0.6, 0.36, 0.58, 0.58, 0.71, 0.46 ], "eps_nri_estimate": [ 0.72, 0.7, 0.85, 0.68, 0.65, 0.64, 0.81, 0.66 ], "dividend_estimate": [ 0.43, 0.43, 0.43, 0.43, 0.44, 0.44, 0.44, 0.44 ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ 4824.83, 4683.75, 5844.96, 4544.21, 4825, 4801, 5731, 3984 ], "operating_cash_flow_per_share_estimate": [ 0.64, 0.94, 1.14, 0.17, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 78.25, 76.1, 75.13, 72.38, 76, 76, 74.3, 74 ], "operating_cash_flow_estimate": [ 3633.47, 5350.07, 6523.08, 944.13, null, null, null, null ], "pettm_estimate": [ 13.5, 13.31, 13.14, 12.51, 11.94, null, null, null ], "long_term_growth_rate_mean": -8.1, "long_term_revenue_growth_rate_mean": "-4.19", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": -8.1, "future_revenue_estimate_growth": -4.19, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": 25.39, "future_book_value_per_share_estimate_growth": 2.31, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }